2024 Q3 Form 10-K Financial Statement

#000149315224036953 Filed on September 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024
Revenue $998.4K $727.8K $3.112M
YoY Change 25.41% 65.41% 147.58%
Cost Of Revenue $525.5K -$87.73K $1.686M
YoY Change -6.79% -122.49% 81.27%
Gross Profit $346.8K $815.6K $1.426M
YoY Change 49.27% 1531.1% 336.41%
Gross Profit Margin 34.74% 112.05% 45.81%
Selling, General & Admin $1.949M $2.671M $9.259M
YoY Change -20.77% 9.9% 15.3%
% of Gross Profit 562.0% 327.46% 649.43%
Research & Development $948.8K $750.1K $1.674M
YoY Change 848.75% 476.99% 228.2%
% of Gross Profit 273.57% 91.97% 117.41%
Depreciation & Amortization $241.6K $236.5K $974.4K
YoY Change -2.41% 114.96% 19.63%
% of Gross Profit 69.67% 28.99% 68.35%
Operating Expenses $3.198M $3.627M $12.13M
YoY Change 11.49% 34.34% -11.17%
Operating Profit -$2.725M -$2.812M -$10.28M
YoY Change 7.87% 6.1% -18.36%
Interest Expense $30.46K $16.36K $92.24K
YoY Change -66.16% -45.47% -95.22%
% of Operating Profit
Other Income/Expense, Net $30.46K $92.24K
YoY Change -67.57% -95.22%
Pretax Income -$2.695M -$2.795M -$10.19M
YoY Change 10.9% 4.7% -4.4%
Income Tax
% Of Pretax Income
Net Earnings -$2.686M -$2.784M -$10.16M
YoY Change 10.74% 4.67% -4.47%
Net Earnings / Revenue -268.99% -382.55% -326.4%
Basic Earnings Per Share -$0.70 -$6.38
Diluted Earnings Per Share -$0.70 -$0.92 -$6.38
COMMON SHARES
Basic Shares Outstanding 4.250M shares 3.117M shares 1.593M shares
Diluted Shares Outstanding 3.811M shares 1.593M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.989M $6.304M $6.304M
YoY Change 1999.7% 309.36% 309.36%
Cash & Equivalents $3.990M $6.300M
Short-Term Investments
Other Short-Term Assets $396.2K $497.6K $474.3K
YoY Change -4.14% -9.99% -7.01%
Inventory $738.8K $777.5K $777.5K
Prepaid Expenses $363.1K
Receivables $578.6K $429.7K $429.7K
Other Receivables $648.3K $6.301K $548.7K
Total Short-Term Assets $6.479M $8.534M $8.534M
YoY Change 140.68% 120.95% 121.09%
LONG-TERM ASSETS
Property, Plant & Equipment $586.1K $565.9K $872.6K
YoY Change -11.85% -18.01% -29.63%
Goodwill
YoY Change
Intangibles $4.400M $4.372M
YoY Change -9.69% -16.81%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.247M $5.245M $5.245M
YoY Change -12.68% -19.21% -19.19%
TOTAL ASSETS
Total Short-Term Assets $6.479M $8.534M $8.534M
Total Long-Term Assets $5.247M $5.245M $5.245M
Total Assets $11.73M $13.78M $13.78M
YoY Change 34.77% 33.07% 33.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.834M $1.705M $602.3K
YoY Change -49.47% 42.05% -49.81%
Accrued Expenses $759.1K $607.2K $1.351M
YoY Change 20.49% -21.87% -0.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $499.6K $515.3K $515.3K
YoY Change 46.94% 47.22% 47.22%
Total Short-Term Liabilities $5.679M $5.451M $5.451M
YoY Change -17.05% -7.36% -7.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $97.84K $144.9K $144.9K
YoY Change -68.44% -61.86% -61.86%
Total Long-Term Liabilities $97.84K $144.9K $144.9K
YoY Change -84.22% -81.42% -81.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.679M $5.451M $5.451M
Total Long-Term Liabilities $97.84K $144.9K $144.9K
Total Liabilities $5.777M $5.596M $5.450M
YoY Change -22.61% -16.08% -16.93%
SHAREHOLDERS EQUITY
Retained Earnings -$54.65M -$51.96M
YoY Change 23.55% 24.28%
Common Stock $43.78K $34.56K
YoY Change 87.84% 48.29%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.00 $1.00
YoY Change -92.86% -92.86%
Treasury Stock Shares
Shareholders Equity $6.105M $8.329M $8.329M
YoY Change
Total Liabilities & Shareholders Equity $11.73M $13.78M $13.78M
YoY Change 34.77% 33.07% 33.13%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024
OPERATING ACTIVITIES
Net Income -$2.686M -$2.784M -$10.16M
YoY Change 10.74% 4.67% -4.47%
Depreciation, Depletion And Amortization $241.6K $236.5K $974.4K
YoY Change -2.41% 114.96% 19.63%
Cash From Operating Activities -$2.387M -$2.944M -$9.572M
YoY Change 81.98% 398.98% 29.74%
INVESTING ACTIVITIES
Capital Expenditures $5.370K $5.368K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$162.0K -$216.1K
YoY Change -10.02% -68.69%
Cash From Investing Activities -$167.3K -$221.4K
YoY Change -7.04% -68.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $42.45K 5.360K $14.56M
YoY Change -89.28% 914.44%
NET CHANGE
Cash From Operating Activities -$2.387M -2.944M -$9.572M
Cash From Investing Activities -167.3K -$221.4K
Cash From Financing Activities $42.45K 5.360K $14.56M
Net Change In Cash -$2.315M -3.106M $4.767M
YoY Change 71.35% 331.38% -171.14%
FREE CASH FLOW
Cash From Operating Activities -$2.387M -$2.944M -$9.572M
Capital Expenditures $5.370K $5.368K
Free Cash Flow -$2.949M -$9.577M
YoY Change 29.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 INBS Government Support Income
GovernmentSupportIncome
737628 usd
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001725430
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2023 INBS Stock Issued During Period Reverse Stock Split Rounding Adjustment
StockIssuedDuringPeriodReverseStockSplitRoundingAdjustment
usd
CY2023 INBS Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2024 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2024 INBS Stock Issued During Period Reverse Stock Split Rounding Adjustment
StockIssuedDuringPeriodReverseStockSplitRoundingAdjustment
usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2024 INBS Non Cash Refund Of Research And Development Expenditure Claims
NonCashRefundOfResearchAndDevelopmentExpenditureClaims
usd
CY2024 INBS Fair Value Gain On Revaluation Of Convertible Notes
FairValueGainOnRevaluationOfConvertibleNotes
usd
CY2024 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
CY2024 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2024 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2024 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2024 INBS Payment Of Equity Issuance Costs Relating To Acquisition
PaymentOfEquityIssuanceCostsRelatingToAcquisition
usd
CY2024 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
usd
CY2024 us-gaap Stock Issued1
StockIssued1
usd
CY2024 INBS Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
usd
CY2024 INBS Deferred Consideration Payable For Business Combination
DeferredConsiderationPayableForBusinessCombination
usd
CY2024 INBS Recording Of Rightofuse Asset And Lease Liability
RecordingOfRightofuseAssetAndLeaseLiability
usd
CY2024 INBS Conversion Of Convertible Notes Payable Into Preferred Stock
ConversionOfConvertibleNotesPayableIntoPreferredStock
usd
CY2023 INBS Conversion Of Holdback Series Preferred Stock Into Common Stock
ConversionOfHoldbackSeriesPreferredStockIntoCommonStock
usd
CY2023 INBS Issuance Of Common Stock Upon Cashless Exercise Of Series F Warrants
IssuanceOfCommonStockUponCashlessExerciseOfSeriesFWarrants
usd
CY2024Q2 INBS Provision For Inventory Obsolescence
ProvisionForInventoryObsolescence
usd
CY2024Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
usd
CY2024Q2 INBS Deferred Consideration Current
DeferredConsiderationCurrent
usd
CY2023Q2 INBS Goods And Services Tax Payable Current
GoodsAndServicesTaxPayableCurrent
usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 INBS Income Tax Reconciliation Tax Benefit On Carry Forward Losses Of Acquired Business
IncomeTaxReconciliationTaxBenefitOnCarryForwardLossesOfAcquiredBusiness
usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
5986356 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4249782 shares
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024 dei Auditor Firm
AuditorFirmId
1195
CY2024 dei Auditor Name
AuditorName
UHY LLP
CY2024 dei Auditor Location
AuditorLocation
Melville, New York
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6304098 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1537244 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
429704 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
293861 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
777537 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
979907 usd
CY2024Q2 INBS Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
525332 usd
CY2023Q2 INBS Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
498758 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
497572 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
552791 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
8534243 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
3862561 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
565850 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
690175 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
306744 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
546475 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4372026 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5255401 usd
CY2024Q2 us-gaap Assets
Assets
13778863 usd
CY2023Q2 us-gaap Assets
Assets
10354612 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1704568 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2610028 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
274834 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
223447 usd
CY2024Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
2486668 usd
CY2023Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
2338057 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
469381 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
358942 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
515282 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
353211 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5450733 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5883685 usd
CY2024Q2 INBS Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
63615 usd
CY2023Q2 INBS Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
24902 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
81324 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
356165 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
402862 usd
CY2024Q2 us-gaap Liabilities
Liabilities
5595672 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6667614 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3456000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3456000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
194200 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
194200 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
34557 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1942 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
116 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
116 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
60971740 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
46180112 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51964332 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41807573 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-712614 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-575496 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
8329350 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3798984 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-146159 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-111986 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8183191 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3686998 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13778863 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10354612 usd
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-12
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3111781 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256872 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
1686155 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
930204 usd
CY2024 us-gaap Gross Profit
GrossProfit
1425626 usd
CY2023 us-gaap Gross Profit
GrossProfit
326668 usd
CY2024 INBS Government Support Income
GovernmentSupportIncome
424776 usd
CY2024 INBS Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
1673806 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1201274 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
966732 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4158670 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
12133576 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
13659529 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-10283174 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-12595233 usd
CY2024 us-gaap Interest Expense Other
InterestExpenseOther
167140 usd
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
223534 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1178 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-9829 usd
CY2024 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
175738 usd
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2154365 usd
CY2024 us-gaap Interest And Other Income
InterestAndOtherIncome
84822 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
9676 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
92242 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1930678 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-10190932 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-10664555 usd
CY2024 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-34173 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32835 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-10156759 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10631720 usd
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-137118 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
212639 usd
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-137118 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
212639 usd
CY2024 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10328050 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10451916 usd
CY2024 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-34173 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-32835 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10293877 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10419081 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.38
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.38
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-127.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-127.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1592746 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1592746 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83717 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83717 shares
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-12
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2023 us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
938 shares
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4724270 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
162460 usd
CY2023 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
260000 usd
CY2023 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
14407 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2093667 usd
CY2023 INBS Stock Issued During Period Value Conversion Of Convertible Notes Payable Into Series C Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertibleNotesPayableIntoSeriesCPreferredStock
367153 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
212639 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3686998 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3686998 usd
CY2024 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3786164 usd
CY2024 INBS Stock Issued During Period Value Conversion Of Holdback Series C Preferred Stock Into Common Stock
StockIssuedDuringPeriodValueConversionOfHoldbackSeriesCPreferredStockIntoCommonStock
32762 usd
CY2024 INBS Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
429 usd
CY2024 INBS Stock Issued During Period Value Exercise Of Warrant
StockIssuedDuringPeriodValueExerciseOfWarrant
1651498 usd
CY2024 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
216821 usd
CY2024 INBS Stock Issued During Period Value Series Ih1 And H2 Warrants Net Of Issuance Costs
StockIssuedDuringPeriodValueSeriesIH1AndH2WarrantsNetOfIssuanceCosts
9117581 usd
CY2024 INBS Stock Issued During Period Value Exercise Of Prefunded Warrants
StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants
5313 usd
CY2024 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
13675 usd
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-137118 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-10190932 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8183191 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8183191 usd
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-12
CY2024 us-gaap Profit Loss
ProfitLoss
-10190932 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-10664555 usd
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
974355 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
814481 usd
CY2024 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
238730 usd
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
152251 usd
CY2024 INBS Noncash Gain Loss On Foreign Currency Translation Net
NoncashGainLossOnForeignCurrencyTranslationNet
-1178 usd
CY2023 INBS Noncash Gain Loss On Foreign Currency Translation Net
NoncashGainLossOnForeignCurrencyTranslationNet
-9829 usd
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6772 usd
CY2024 us-gaap Inventory Write Down
InventoryWriteDown
69676 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
189670 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4158670 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
230496 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
260000 usd
CY2023 INBS Non Cash Refund Of Research And Development Expenditure Claims
NonCashRefundOfResearchAndDevelopmentExpenditureClaims
127944 usd
CY2023 INBS Fair Value Gain On Revaluation Of Convertible Notes
FairValueGainOnRevaluationOfConvertibleNotes
-1537565 usd
CY2024 INBS Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
-175738 usd
CY2023 INBS Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
-616800 usd
CY2024 INBS Noncash Other Operating Activities
NoncashOtherOperatingActivities
24177 usd
CY2023 INBS Noncash Other Operating Activities
NoncashOtherOperatingActivities
94332 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
135843 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
293861 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-202370 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
345390 usd
CY2024 INBS Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
-148611 usd
CY2023 INBS Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
-1031357 usd
CY2024 INBS Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
26574 usd
CY2023 INBS Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
145710 usd
CY2024 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-55219 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
118335 usd
CY2024 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-632950 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
84502 usd
CY2024 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-364149 usd
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-25724 usd
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
51387 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-107922 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9571569 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7377378 usd
CY2023 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
174481 usd
CY2023 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
363500 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5368 usd
CY2024 INBS Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
216058 usd
CY2023 INBS Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
505123 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-221426 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-694142 usd
CY2024 INBS Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
3786164 usd
CY2023 INBS Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
2554463 usd
CY2024 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1656811 usd
CY2024 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9117581 usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
220578 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
518914 usd
CY2023 INBS Payment Of Equity Issuance Costs Relating To Acquisition
PaymentOfEquityIssuanceCostsRelatingToAcquisition
806397 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14407 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14560556 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1435323 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-707 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-64860 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4766854 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6701057 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1537244 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8238301 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6304098 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1537244 usd
CY2023 us-gaap Stock Issued1
StockIssued1
5530667 usd
CY2023 INBS Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
504938 usd
CY2023 INBS Deferred Consideration Payable For Business Combination
DeferredConsiderationPayableForBusinessCombination
208500 usd
CY2023 INBS Recording Of Rightofuse Asset And Lease Liability
RecordingOfRightofuseAssetAndLeaseLiability
702566 usd
CY2023 INBS Conversion Of Convertible Notes Payable Into Preferred Stock
ConversionOfConvertibleNotesPayableIntoPreferredStock
367153 usd
CY2024 INBS Conversion Of Preferred Stock Into Common Stock
ConversionOfPreferredStockIntoCommonStock
57287 usd
CY2023 INBS Conversion Of Preferred Stock Into Common Stock
ConversionOfPreferredStockIntoCommonStock
36888 usd
CY2024 INBS Conversion Of Holdback Series Preferred Stock Into Common Stock
ConversionOfHoldbackSeriesPreferredStockIntoCommonStock
32762 usd
CY2024 INBS Issuance Of Common Stock Upon Cashless Exercise Of Series F Warrants
IssuanceOfCommonStockUponCashlessExerciseOfSeriesFWarrants
6551 usd
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-12
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-12
CY2023Q4 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
4380000 usd
CY2023Q4 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
3790000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
1770000 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
1580000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
10100000 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
9120000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-10160000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8180000 usd
CY2024Q2 INBS Working Capital Deficit
WorkingCapitalDeficit
3080000.00 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51960000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6300000 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
137118 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
212639 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_z4S9OeI0jW33" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zaGNKKzVNSUb">Use of estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates made by management in connection with the preparation of the accompanying consolidated financial statements including the fair value measurement of and the useful lives of long-lived assets, inventory valuations, the allocation of transaction price among various performance obligations, and the allowance for credit losses. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zoxBMR02k1Ml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of credit risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places its cash and cash equivalents, which may at times be in excess of the Australia Financial Claims Scheme, Financial Services Compensation Scheme or the United States’ Federal Deposit Insurance Corporation insurance limits, with high credit quality financial institutions and attempts to limit the amount of credit exposure with any one institution. The amounts over these insured limits as of June 30, 2024 and 2023 were $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zXhpJZtJeGLj" title="Cash FDIC insured amount">5,781,130</span> and $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20230630_zhSMSsfIQbc9" title="Cash FDIC insured amount">1,114,687</span>, respectively. No losses have been incurred to date on any deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
5781130 usd
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
1114687 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4200000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3111781 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256872 usd
CY2021Q2 us-gaap Deferred Income
DeferredIncome
4700000 usd
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
543410 usd
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
646116 usd
CY2021Q2 us-gaap Deferred Income
DeferredIncome
4700000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1650000 usd
CY2024 INBS Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
424776 usd
CY2023 INBS Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
609684 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3111781 usd
CY2024 INBS Government Support Income
GovernmentSupportIncome
424776 usd
CY2024 INBS Revenue And Government Support Income
RevenueAndGovernmentSupportIncome
3536557 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-10190932 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256872 usd
CY2023 INBS Government Support Income
GovernmentSupportIncome
737628 usd
CY2023 INBS Revenue And Government Support Income
RevenueAndGovernmentSupportIncome
1994500 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-10664555 usd
CY2024Q2 INBS Long Lived Assets
LongLivedAssets
5244620 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
777537 usd
CY2024Q2 INBS Long Lived Assets And Inventory
LongLivedAssetsAndInventory
6022157 usd
CY2023Q2 INBS Long Lived Assets
LongLivedAssets
6492051 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
979907 usd
CY2023Q2 INBS Long Lived Assets And Inventory
LongLivedAssetsAndInventory
7471958 usd
CY2023 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1256872 usd
CY2023 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-10664555 usd
CY2023 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-10631720 usd
CY2023 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-127.00
CY2023 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-127.00
CY2024Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
188693 usd
CY2023Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
419889 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
588844 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
757518 usd
CY2023Q2 INBS Provision For Inventory Obsolescence
ProvisionForInventoryObsolescence
197500 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
777537 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
979907 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
363071 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
359953 usd
CY2024Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
17011 usd
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
20418 usd
CY2024Q2 us-gaap Deposit Assets
DepositAssets
111189 usd
CY2023Q2 us-gaap Deposit Assets
DepositAssets
118193 usd
CY2023Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
34100 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6301 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
20127 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
497572 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
552791 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
626625 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
723944 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60775 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33769 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
565850 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
690175 usd
CY2024 us-gaap Depreciation
Depreciation
15108 usd
CY2023 us-gaap Depreciation
Depreciation
33769 usd
CY2023Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
509416 usd
CY2024Q2 INBS Percentage Of Reimbursement On Construction Cost
PercentageOfReimbursementOnConstructionCost
0.50 pure
CY2024Q2 INBS Investments In Construction In Progress
InvestmentsInConstructionInProgress
1086820 usd
CY2023Q2 INBS Investments In Construction In Progress
InvestmentsInConstructionInProgress
1292232 usd
CY2024Q2 INBS Government Grant
GovernmentGrant
543410 usd
CY2023Q2 INBS Government Grant
GovernmentGrant
646116 usd
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
543410 usd
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
646116 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5463000 usd
CY2024Q2 INBS Effect Of Foreign Currency On Intangible Assets
EffectOfForeignCurrencyOnIntangibleAssets
632878 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1723852 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4372026 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5463000 usd
CY2023Q2 INBS Effect Of Foreign Currency On Intangible Assets
EffectOfForeignCurrencyOnIntangibleAssets
643183 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
850782 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5255401 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1723852 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
850782 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
947436 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
805764 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
884627 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
814329 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
790896 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
790896 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
790896 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
197724 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4269368 usd
CY2024Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
602337 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1196222 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
607176 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
777086 usd
CY2023Q2 INBS Deferred Consideration Current
DeferredConsiderationCurrent
208500 usd
CY2024Q2 INBS Goods And Services Tax Payable Current
GoodsAndServicesTaxPayableCurrent
50283 usd
CY2024Q2 INBS Accrued Compensation And Related Payables
AccruedCompensationAndRelatedPayables
444772 usd
CY2023Q2 INBS Accrued Compensation And Related Payables
AccruedCompensationAndRelatedPayables
428220 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1704568 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2610028 usd
CY2024 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
500000 shares
CY2024 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
6248 shares
CY2024Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0097 pure
CY2024 INBS Percentage Of Gross Revenue Received
PercentageOfGrossRevenueReceived
0.10 pure
CY2024 INBS Percentage Of Sales To Distributor
PercentageOfSalesToDistributor
0.50 pure
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
238730 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
152251 usd
CY2024 INBS Interest On Operating Lease Liabilities
InterestOnOperatingLeaseLiabilities
71667 usd
CY2023 INBS Interest On Operating Lease Liabilities
InterestOnOperatingLeaseLiabilities
68357 usd
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
310397 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
220608 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.132 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.132 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
308770 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
83509 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
392279 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
36121 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
356158 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6310684 shares
CY2023Q4 INBS Underwriters Warrants Purchase Percentage
UnderwritersWarrantsPurchasePercentage
0.050 pure
CY2024 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
500000 shares
CY2024 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
6248 shares
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10421568 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9530704 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
4182278 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
3914445 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
6090380 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
5347487 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
118132 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
153199 usd
CY2024Q2 INBS Deferred Tax Assets Inventory Inventory Adjustments
DeferredTaxAssetsInventoryInventoryAdjustments
-1124 usd
CY2023Q2 INBS Deferred Tax Assets Inventory Inventory Adjustments
DeferredTaxAssetsInventoryInventoryAdjustments
38034 usd
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
31902 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
77539 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10421568 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9530704 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10421568 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9530704 usd
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1848116 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2310635 usd
CY2024 INBS Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
-99401 usd
CY2023 INBS Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
-18715 usd
CY2024 INBS Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
246168 usd
CY2023 INBS Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
680221 usd
CY2023 INBS Income Tax Reconciliation Tax Benefit On Carry Forward Losses Of Acquired Business
IncomeTaxReconciliationTaxBenefitOnCarryForwardLossesOfAcquiredBusiness
-3289886 usd
CY2024 INBS Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
797234 usd
CY2023 INBS Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
1681562 usd
CY2024 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
13250 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-209226 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
890865 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3466679 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
49097053 usd
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
44492527 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-10156759 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10631720 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.38
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.38
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-127.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-127.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1592746 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1592746 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83717 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83717 shares

Files In Submission

Name View Source Status
0001493152-24-036953-index-headers.html Edgar Link pending
0001493152-24-036953-index.html Edgar Link pending
0001493152-24-036953.txt Edgar Link pending
0001493152-24-036953-xbrl.zip Edgar Link pending
ex19-1.htm Edgar Link pending
ex19-1_001.jpg Edgar Link pending
ex19-1_002.jpg Edgar Link pending
ex19-1_003.jpg Edgar Link pending
ex19-1_004.jpg Edgar Link pending
ex19-1_005.jpg Edgar Link pending
ex19-1_006.jpg Edgar Link pending
ex19-1_007.jpg Edgar Link pending
ex19-1_008.jpg Edgar Link pending
ex19-1_009.jpg Edgar Link pending
ex19-1_010.jpg Edgar Link pending
ex19-1_011.jpg Edgar Link pending
ex19-1_012.jpg Edgar Link pending
ex19-1_013.jpg Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-1_001.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-13.htm Edgar Link pending
ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
inbs-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
inbs-20240630_cal.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
inbs-20240630_def.xml Edgar Link unprocessable
inbs-20240630_pre.xml Edgar Link unprocessable
inbs-20240630_lab.xml Edgar Link unprocessable